Overview

Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes

Status:
Terminated
Trial end date:
2008-04-02
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA) and Canada. The aim of this research is to compare the efficacy (reduction in HbA1c and blood glucose) and pulmonary safety (pulmonary function, chest x-rays) of mealtime inhaled insulin with subcutaneous insulin aspart both in combination with insulin determir in Type 1 Diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Aspart
Insulin Detemir
Insulin, Globin Zinc